Search research articles
Contact Us
Filters
Showing results (81-90 of 141) with videos related to
Page
of 15
Sort By:
Leukemia & Lymphoma
|
July 12, 2011
Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone
Jana Markova, Deniz Kahraman, Carsten Kobe, et al.
Molecular Imaging and Biology
|
October 2, 2020
[<sup>18</sup>F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer
Felix Dietlein, Peter Mueller, Carsten Kobe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2012
[18F]Fluorodeoxyglucose positron emission tomography/computed tomography-positive gastric adenocarcinoma in a 12-year-old girl with Peutz-Jeghers syndrome
Christina Schneider, Thorsten Simon, Barbara Hero, et al.
Clinical Nuclear Medicine
|
October 3, 2012
Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinib
Deniz Kahraman, Arne Holstein, Matthias Scheffler, et al.
Molecular Imaging and Biology
|
August 9, 2021
Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer
Sergio Muñoz Vázquez, Heike Endepols, Thomas Fischer, et al.
Plos One
|
December 21, 2018
Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT
Jochen Hammes, Melanie Hohberg, Philipp Täger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 11, 2025
Association between metabolic tumor burden and health-related quality of life in patients with classic Hodgkin lymphoma
Marie Lommen, Jasmin J Weindler, Janina Jablonski, et al.
Journal of Alzheimer'S Disease : JAD
|
January 24, 2022
Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease
Nils Richter, Lara-Sophia David, Michel J Grothe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
An <sup>89</sup>Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients
Felix Dietlein, Carsten Kobe, Sergio Muñoz Vázquez, et al.
Blood
|
September 1, 2018
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma
Carsten Kobe, Helen Goergen, Christian Baues, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 141) with videos related to
Sort By:
Page
of 15
Leukemia & Lymphoma
|
July 12, 2011
Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone
Jana Markova, Deniz Kahraman, Carsten Kobe, et al.
Molecular Imaging and Biology
|
October 2, 2020
[<sup>18</sup>F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer
Felix Dietlein, Peter Mueller, Carsten Kobe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2012
[18F]Fluorodeoxyglucose positron emission tomography/computed tomography-positive gastric adenocarcinoma in a 12-year-old girl with Peutz-Jeghers syndrome
Christina Schneider, Thorsten Simon, Barbara Hero, et al.
Clinical Nuclear Medicine
|
October 3, 2012
Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinib
Deniz Kahraman, Arne Holstein, Matthias Scheffler, et al.
Molecular Imaging and Biology
|
August 9, 2021
Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer
Sergio Muñoz Vázquez, Heike Endepols, Thomas Fischer, et al.
Plos One
|
December 21, 2018
Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT
Jochen Hammes, Melanie Hohberg, Philipp Täger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 11, 2025
Association between metabolic tumor burden and health-related quality of life in patients with classic Hodgkin lymphoma
Marie Lommen, Jasmin J Weindler, Janina Jablonski, et al.
Journal of Alzheimer'S Disease : JAD
|
January 24, 2022
Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease
Nils Richter, Lara-Sophia David, Michel J Grothe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
An <sup>89</sup>Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients
Felix Dietlein, Carsten Kobe, Sergio Muñoz Vázquez, et al.
Blood
|
September 1, 2018
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma
Carsten Kobe, Helen Goergen, Christian Baues, et al.
Page
of 15